The pharmaceutical company says it is buying Loxo Oncology for $235 a share in cash, a deal that expands the company’s cancer-treatment portfolio.
"She bleeds from the tumor...and suffers from convulsion fits in her throat," says Diyal Atwat of besieged Eastern Ghouta whose three-year-old daughter Rama suffers from cancer and is facing acute medicine shortage in the opposition-held enclave.
Subscribe to our Youtube channel for all latest in-depth, on the ground reporting from around the world.
Copyright © 2023 TRT World.
Like
Follow